This review analyzed data from 262 patients with acute graft-versus-host disease, a complication after stem cell transplants. It compared fecal microbial transplantation (FMT) to conventional treatment with corticosteroids or immunosuppressants.
The study found no significant difference in the overall incidence of the disease between the two groups. However, for patients with gastrointestinal symptoms, FMT was linked to significantly higher response rates at 14 and 30 days. The analysis also found no increased risk of bloodstream infections like bacteremia or sepsis with FMT.
The main reason to be careful is that this is a meta-analysis of a small number of patients. The findings suggest FMT could be an effective option for patients who do not respond well to standard drugs, but more research is needed to confirm these results.
Readers should understand this shows a potential link, not a proven cure. It highlights a possible treatment path for a difficult condition, but it is not yet standard practice.